US stocks slip on fears of new virus wave

US stocks slip on fears of new virus wave

The S&P 500 and Dow Jones indexes have retreated after last week’s rally, as investors worry about a second wave of coronavirus infections with the reopening of several economies. Germany and South Korea reported a surge in new COVID-19 cases on Sunday, in...
US stocks slip on fears of new virus wave

Helloworld says can survive virus downturn

Travel company Helloworld expects revenues to be just 5 per cent of pre-COVID levels between April and September and is forecasting losses of $1.5 million to $2 million a month until then. But with $150 million in cash reserves Helloworld says it is positioned to...
US stocks slip on fears of new virus wave

Aussie shares to gain on virus drug hopes

Shares on the Australian market are set for gains after US stocks surged overnight after promising results for a COVID-19 treatment. The Australian SPI 200 futures contract was up 108 points, or 2.01 per cent, at 5,468.0 points at 0700 AEST on Thursday. Big tech...
US stocks slip on fears of new virus wave

Wall Street jumps on hopes for virus drug

Wall Street has jumped as Gilead Sciences gave an encouraging update on a potential COVID-19 treatment and upbeat earnings from Google-parent Alphabet boosted shares of other technology and internet giants. Gilead rose 4.8 per cent after the drugmaker said its...
US stocks slip on fears of new virus wave

Google’s growth slows as virus hits ads

Google has reported its weakest revenue growth in nearly five years in the first quarter as the pandemic-driven recession began to shrivel its advertising sales. The January-March earnings for Google parent Alphabet offer a first look at how the digital ad market has...